Bill H.R.8421 titled “To preempt States from establishing, implementing, or enforcing any ban on the prescription, provision, or use of a drug, biological product, or device for contraception if such drug, biological product, or device is approved, licensed, cleared, or otherwise authorized for human use by the Food and Drug Administration for contraception, and for other purposes” was referred to the House Committee on Energy and Commerce by the House of Representatives. The bill is sponsored by Rep. Stephanie Bice with Don Bacon, Andy Barr, Earl Carter, Tom Cole, John Curtis, J. Hill, Darrell Issa, Doug Lamborn, Julia Letlow, Mariannette Miller-Meeks, Cathy Rodgers, Elise Stefanik as cosponsors.
Bill H.R.8424 titled “To provide enhanced funding for family planning services” was referred to the House Committee on Energy and Commerce by the House of Representatives. The bill is sponsored by Rep. Sharice Davids.
Bill H.R.8428 titled “To allow women greater access to safe and effective oral contraceptive drugs intended for routine use” was referred to the Committee on Ways and Means and in addition to the Committee on Energy and Commerce for a period to be subsequently determined by the Speaker in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned by the House of Representatives. The bill is sponsored by Rep. Ashley Hinson with Nancy Mace, Mariannette Miller-Meeks, Cathy Rodgers, Jason Smith as cosponsors.
The Energy and Commerce Committee moves forward in some way on two bills per day, taking one action on average per day.
Most bills have a hearing where those involved explain why they are for or against the bill. Roughly 8,000 bills are addressed by committees each year but only about 800 make it to the floor of Congress, according to ushistory.org.
A 2019 report from the Brookings Institute argued committees aren’t capable of delving fully into the issues they address and are forced to rely on lobbyists.
Bill Name | Sponsor | Action |
---|---|---|
To preempt States from establishing, implementing, or enforcing any ban on the prescription, provision, or use of a drug, biological product, or device for contraception if such drug, biological product, or device is approved, licensed, cleared, or otherwise authorized for human use by the Food and Drug Administration for contraception, and for other purposes. | Rep. Bice, Stephanie I. | House of Representatives |
To provide enhanced funding for family planning services. | Rep. Davids, Sharice | House of Representatives |
To allow women greater access to safe and effective oral contraceptive drugs intended for routine use. | Rep. Hinson, Ashley | House of Representatives |